CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 30 enrolled
Drug / intervention
Spinal Cord Stimulationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03284411
NCT03284411Phase 4Completed

Spinal Cord Stimulation (SCS) Dosing Study

MedtronicNeuro·interventional·Posted Sep 15, 2017·Updated Apr 15, 2020

In Brief

A Phase 4 clinical trial evaluating Spinal Cord Stimulation for Back Pain and Leg Pain. Completed, enrolled 30 participants across 10 sites.

Detailed Summary

This study characterized the effects of amplitude on subject satisfaction and pain relief in subjects being treated by SCS.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBack Pain, Leg Pain
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
201820192020202120222023202420252026
First PostedSep 15, 2017
Enrollment StartNov 1, 2017
Primary CompletionMar 15, 2019
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 8.8 years ago

Interventions

Spinal Cord Stimulationdevice

Programming